Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 61 AL 75

Can nutrients prevent or delay onset of Alzheimer's disease?

Kamphuis PJ, Scheltens P.

J Alzheimers Dis. 2010;20(3):765-75. doi: 10.3233/JAD-2010-091558.

Evidence-based medicine: application in Alzheimer's disease research

Murad MH, Montori VM.

J Alzheimers Dis. 2010;20(3):935-42. doi: 10.3233/JAD-2010-1419.

Effectiveness of the Mediterranean diet: can it help delay or prevent Alzheimer's disease?

Sofi F, Macchi C, Abbate R, Gensini GF, Casini A.

J Alzheimers Dis. 2010;20(3):795-801. doi: 10.3233/JAD-2010-1418.

[Fullerenes C60, antiamyloid action, the brain and cognitive processes]

Podol'skiĭ IIa, Poddubnaia ZA, Godukhin OV.

Biofizika. 2010 Jan-Feb;55(1):88-94.

Protein aggregation diseases: pathogenicity and therapeutic perspectives

Aguzzi A, O'Connor T.

Nat Rev Drug Discov. 2010 Mar;9(3):237-48. doi: 10.1038/nrd3050.

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

Feldman HH, Doody RS, Kivipelto M, Sparks DL, Waters DD, Jones RW, Schwam E, Schindler R, Hey-Hadavi J, DeMicco DA, Breazna A; LEADe Investigators.

Neurology. 2010 Mar 23;74(12):956-64. doi: 10.1212/WNL.0b013e3181d6476a. Epub 2010 Mar 3.

[Caregiver burden with dementia patients. A validation study of the German language version of the Zarit Burden Interview]

Braun M, Scholz U, Hornung R, Martin M.

Z Gerontol Geriatr. 2010 Apr;43(2):111-9. doi: 10.1007/s00391-010-0097-6. Epub 2010 Mar 5.

Amyloid-beta immunotherapy for Alzheimer's disease

Fu HJ, Liu B, Frost JL, Lemere CA.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):197-206. doi: 10.2174/187152710791012017.

Re-balancing of inflammation and abeta immunity as a therapeutic for Alzheimer's disease-view from the bedside

Fiala M.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):192-6. doi: 10.2174/187152710791012044.

Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease

Cole GM, Frautschy SA.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):140-8. doi: 10.2174/187152710791011991.

The pulse of drug development for Alzheimer's disease

Rafii MS.

Rev Recent Clin Trials. 2010 Jan;5(1):57-62. doi: 10.2174/157488710790820490.

From alpha to omega with Abeta: targeting the multiple molecular appearances of the pathogenic peptide in Alzheimer's disease

De Kimpe L, Scheper W.

Curr Med Chem. 2010;17(3):198-212. doi: 10.2174/092986710790149765.

Methylphenidate for apathy and functional status in dementia of the Alzheimer type

Padala PR, Burke WJ, Shostrom VK, Bhatia SC, Wengel SP, Potter JF, Petty F.

Am J Geriatr Psychiatry. 2010 Apr;18(4):371-4. doi: 10.1097/JGP.0b013e3181cabcf6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias